title: [Venous thromboembolism and pregnancy].
abstract: Venous thromboembolism (VTE) is a major cause of maternal morbidity and mortality during or early after pregnancy. Prior VTE or family history of VTE, clinical or biological risk factors increased the risk of pregnancy-related VTE. Defining the risk of VTE before or at the beginning of pregnancy is necessary to propose the best prevention. However, the management is not standardized between physicians, centres and countries. Current guidelines for prophylaxis and treatment of VTE are discussed in this review.
authors.affiliation: Service d'hématologie biologique, hôpitaux universitaires Paris Centre-Cochin, 27, rue du Faubourg-Saint-Jacques, 75679 Paris cedex14, France; Faculté de médecine Paris-Descartes, France. Electronic address: marie.horellou@cch.aphp.fr.
authors.forename: M-H
authors.initials: MH
authors.lastname: Horellou
authors.affiliation: Faculté de médecine Paris-Descartes, France; Service de gynécologie médicale, hôpitaux universitaires Paris Centre-Cochin, Paris, France.
authors.forename: G
authors.initials: G
authors.lastname: Plu-Bureau
authors.affiliation: Faculté de médecine Paris-Descartes, France; Service d'obstétrique, hôpitaux universitaires Paris Centre-Cochin, Paris, France.
authors.forename: J
authors.initials: J
authors.lastname: Lepercq
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy; D018570:Risk Assessment; D012307:Risk Factors; D054556:Venous Thromboembolism / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy
chemical_list: D000925:Anticoagulants
keywords: Grossesse; Héparine de bas poids moléculaire; Low molecular weight heparin; Pregnancy; Thrombophilia; Thrombophilie; Thrombose veineuse; Venous thromboembolism